ITGA6 rs12621278: What Your Genotype Means
The rs12621278 variant is a common genetic change located within the ITGA6 gene. Research has investigated its potential role in prostate cancer susceptibility and disease progression, though findings vary across different populations.
What each genotype means
Baseline prostate cancer risk
This genotype is considered the common reference state for this variant. Research indicates that individuals with this genotype do not carry the specific risk allele associated with increased prostate cancer susceptibility or disease progression at this locus.
This is the most common genotype across most studied populations, particularly in individuals of European ancestry.
Increased prostate cancer risk
Carrying one copy of the G allele is statistically associated with an increased risk of prostate cancer and, in some studies, a higher likelihood of disease progression. Because this is a complex genetic association, it should not be viewed as a diagnosis; please discuss any concerns regarding prostate health or screening with your clinician.
This genotype is found in a significant portion of the population, with frequency varying by ancestry.
Elevated prostate cancer risk
Carrying two copies of the G allele is associated with a higher statistical risk for prostate cancer and potential disease progression compared to those without the G allele. This association is based on population-level data and does not guarantee a specific health outcome; please consult with your healthcare provider regarding appropriate prostate cancer screening protocols.
This genotype is less common than the AA or AG genotypes in many populations, though it remains a recognized variant in genetic studies.
Understanding the rs12621278 Variant
The rs12621278 variant is a single nucleotide polymorphism (SNP) located on chromosome 2. In genetic terms, a SNP represents a variation at a single position in the DNA sequence. This specific variant is found within an intronic region of the ITGA6 gene. Introns are non-coding sections of a gene that do not provide direct instructions for making proteins, but they can play important roles in regulating how genes are expressed. Because rs12621278 is located in a regulatory region, researchers have hypothesized that it might influence the activity of the nearby ITGA6 gene, potentially affecting biological processes related to cell structure and signaling.
The Role of the ITGA6 Gene
The ITGA6 gene provides instructions for creating the alpha-6 subunit, a critical component of two specific proteins known as a6b4 integrin and a6b1 integrin. Integrins are proteins that act as bridges between the interior of a cell and its external environment, helping cells attach to their surroundings and communicate with neighboring cells. These proteins are essential for maintaining tissue integrity, such as holding layers of skin together, and they play significant roles in organ development before birth. Because of their involvement in cell adhesion and signaling, researchers have studied whether changes in ITGA6 expression might influence how cells behave, including their ability to grow, migrate, or interact with the surrounding tissue environment in the context of cancer.
Research and Prostate Cancer Associations
Scientific studies have explored the link between rs12621278 and prostate health. Some genome-wide association studies (GWAS) have identified this variant as a potential marker for prostate cancer susceptibility and disease progression. For instance, some research has suggested that the G allele may be associated with an increased risk of prostate cancer or more aggressive disease outcomes. However, the evidence is complex and sometimes inconsistent across different studies and ancestral groups. While some trials have observed associations with disease progression or benign prostatic hyperplasia, other studies have not consistently replicated these findings. It is important to note that these associations are statistical in nature and do not imply that the variant directly causes cancer. Genetic risk is only one of many factors, including age, family history, and lifestyle, that contribute to prostate health.
Population Frequency
The rs12621278 variant is considered a common SNP, meaning it is found frequently across various human populations. Because it is common, many individuals carry one or two copies of the variant alleles. The distribution of these alleles can vary depending on ancestral background, which is a standard observation in human genetics. Researchers often use large-scale databases to track these frequencies to better understand how genetic markers are distributed globally. While the variant is common, its presence does not indicate a specific health outcome, as most people who carry the variant will not develop the conditions being studied.
Interpreting Genetic Information
If you have received information about your rs12621278 genotype, it is important to view it within the context of your overall health. Genetic associations identified in research studies are meant to help scientists understand biological mechanisms, not to provide individual medical diagnoses. You cannot use this information to predict your personal risk of developing prostate cancer or to make decisions about medical treatments. If you have concerns about your prostate health or family history, the most appropriate step is to consult with a healthcare professional, such as a primary care physician or a urologist. They can provide personalized guidance based on your clinical history, physical exams, and established screening guidelines, which are far more predictive of health outcomes than any single genetic variant.
How common is this variant?
The rs12621278 variant is a common genetic marker found across diverse global populations.
Frequently asked questions
Does having the rs12621278 variant mean I will get prostate cancer?
No. Genetic variants like rs12621278 are associated with statistical differences in risk across large populations, but they do not determine an individual's health outcome. Many factors, including age and family history, are much more significant in determining prostate cancer risk.
Should I get tested for this variant?
There is no clinical recommendation to test for this variant. Genetic testing for common variants like rs12621278 is generally not used in routine medical practice because it does not provide actionable information for personal health management.
What should I do if I know my genotype for this SNP?
You should continue to follow standard medical advice for prostate health, such as regular check-ups and screenings as recommended by your doctor. Do not use genetic information to change your medical care or ignore standard screening guidelines.
Is this variant considered a 'mutation'?
In genetics, this is referred to as a variant or polymorphism because it is common in the general population. The term 'mutation' is typically reserved for rare changes that have a direct and significant impact on protein function and health.
Sources & further reading
Educational information only, last refreshed 10/28/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12621278?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29